Schonfeld Strategic Advisors’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$19.2M Buy
58,757
+55,675
+1,806% +$18.2M 0.13% 150
2025
Q1
$832K Sell
3,082
-123,918
-98% -$33.5M 0.01% 1247
2024
Q4
$29.9M Buy
127,000
+99,133
+356% +$23.3M 0.17% 80
2024
Q3
$7.66M Sell
27,867
-16,108
-37% -$4.43M 0.05% 310
2024
Q2
$10.7M Sell
43,975
-191,631
-81% -$46.6M 0.07% 283
2024
Q1
$35.2M Buy
235,606
+233,653
+11,964% +$34.9M 0.23% 64
2023
Q4
$374K Sell
1,953
-40,154
-95% -$7.69M ﹤0.01% 1289
2023
Q3
$7.46M Buy
42,107
+39,641
+1,608% +$7.02M 0.06% 384
2023
Q2
$468K Sell
2,466
-12,770
-84% -$2.43M ﹤0.01% 1211
2023
Q1
$3.05M Buy
+15,236
New +$3.05M 0.03% 580
2022
Q4
Sell
-33,615
Closed -$6.73M 2477
2022
Q3
$6.73M Buy
+33,615
New +$6.73M 0.06% 432
2022
Q2
Sell
-6,700
Closed -$1.09M 2411
2022
Q1
$1.09M Buy
+6,700
New +$1.09M 0.01% 887
2021
Q3
Sell
-18,968
Closed -$3.22M 1966
2021
Q2
$3.22M Buy
18,968
+10,868
+134% +$1.84M 0.03% 546
2021
Q1
$1.14M Buy
+8,100
New +$1.14M 0.01% 806
2019
Q3
Sell
-73,600
Closed -$5.34M 986
2019
Q2
$5.34M Buy
73,600
+10,900
+17% +$791K 0.19% 133
2019
Q1
$5.86M Buy
62,700
+47,700
+318% +$4.46M 0.2% 133
2018
Q4
$1.09M Sell
15,000
-51,500
-77% -$3.76M 0.04% 460
2018
Q3
$5.82M Hold
66,500
0.26% 111
2018
Q2
$6.55M Buy
66,500
+51,500
+343% +$5.07M 0.36% 78
2018
Q1
$1.79M Sell
15,000
-3,575
-19% -$426K 0.13% 218
2017
Q4
$2.36M Buy
+18,575
New +$2.36M 0.19% 147
2016
Q4
Sell
-25,618
Closed -$1.74M 536
2016
Q3
$1.74M Buy
+25,618
New +$1.74M 0.3% 86